Endo Flashcards

1
Q

Things that make A1c unreliable

A
A1c
Epo 
Liver disease
Hemoglobinopathies (Sickle cell disease)
Iron-deficiency anemia (falsely elevated due to an increase in older erythrocytes)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How to test for symptomatic hypoglycemia

A

72-hour fast with hypoglycemic studies at the time of symptomatic hypoglycemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Goal A1c in diabetes

A

Less than 7% (unless older)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Initial management of new onset diabetes

A

Metformin + lifestyle modification for 3 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Management of diabetes after lifestyle modification

A
  • Start metformin if A1c not at goal after 3 months (even if patient making progress. you want to aggressively reduce risk of micro and macrovascular complications)
  • IF A1c remains at 9% or above after 3 months –> add orals
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

SE’s to know with GLP-1 agonists

A
  • Pancreatitis

- Medullary thyroid carcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Physiology of osmotic diuresis following AKI

A

High urea output in urine leads to osmotic diuresis, leading to hypernatremia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Indications for kidney biopsy

A
  • Glomerular hematuria
  • Severely increased albuminuria
  • **Acute or chronic kidney disease of unclear cause
  • kidney transplant dysfunction or monitoring
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Clinical features of cisplatin-induced kidney injury

A

Polyuria and urinary excretion of sodium leading to volume depletion + tubular injury + hypomagnesemia (urinary magnesium loss) + proximal renal tubular acidosis with fanconi syndrome
- 7 days after starting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Lung pathology caused by paclitaxel

A

Diffuse interstitial lung disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How is kidney failure risk determined + variables included

A
  • kidney failure risk equation

- age + sex + eGFR + albuminuria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

diseases associated with AA amyloidosis

A

Chronic inflammatory states (RA) – it’s an acute phase reactant so deposits in numerous tissues, including kidneys

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Amyloidosis labs to know

A

SPEP with polyclonal gammopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Patients at high risk for RCC

A

ESRD patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Bilateral cysts and masses in patient with ESRD think

A

Acquired cystic kidney disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Management of acquired cystic kidney disease in patients with CKD

A

IF severe or higher stage –> bilateral nephrectomy (little use in partial nephrectomy given very little residual kidney function)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

When patients are initiated on dialysis

A

GFR below 7.0 OR conventional indications for dialysis (uremic symptoms, metabolic abnormalities)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

first step in workup of primary adrenal insufficiency + why

A

21-hydroxylase antibodies (looking for autoimmune adrenalitis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

primary adrenal insufficiency means

A

localizes to adrenal gland

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

primary adrenal insufficiency lab profile

A

low serum cortisol + elevated ACTH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

most common cause of primary adrenal insufficiency in US

A

autoimmune adrenalitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

diagnosis of primary adrenal insufficiency

A

just low serum cortisol + elevated ACTh (don’t need cosyntropin stimulation test)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

management of amenorrhea + hyperprolactinemia in psych patient on risperidone

A
  • pituitary MRI (rule out pituitary adenoma)

- talk to psych before discontinuing risperidone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

treatment of primary adrenal insufficiency

A
  • BOTH glucocorticoid and mineralocorticoid replacement (affects all layers of the adrenal cortex)
  • hydrocortisone BID (has shorter duration and BID dosing mimics circadian rhythm of endogenous cortisol secretion)
  • fludrocortisone daily
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Next step after radiographic diagnosis of Paget disease of the bone

A

Serum alkaline phosphatase (need a baseline. it is a marker of treatment efficacy in Paget’s)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

How bisphosphonates cause severe hypocalcemia

A
  • people who are vitamin d deficient can’t correct for calcium deficiency through increased osteoclast activity because antiresorptive drugs suppress osteoclastic bone resorption
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

what to always remember before starting zometa

A

Check vitamin D and correct before starting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Hungry bone syndrome pathophys

A

After parathyroidectomy for primary hyperPTH, rapid influx of calcium from blood into the skeleton causes hypocalcemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Presentation of androgen-producing adrenal tumor

A

signs of androgen excess over short period of time (hirsutism, virilization – deep voice, facial hair)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Workup of suspected androgen secreting adrenal tumor

A

CT abdomen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

New term for euthyroid sick syndrome

A

Nonthyroidal illness syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

lab features of nonthyroidal illness syndrome

A
  • low serum T3
  • low or low-normal serum T4
  • low or normal TSH
  • looks like subclinical hypothyroidism but T4 and T3 or low or low normal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Management of Cushing patient post adrenalectomy

A

Daily glucocorticoid replacement (hypercortisol secretion suppresses hypothalamic axis, when this axis is recovered following removal of the source/adrenalectomy, endogenous cortisol production is impaired. You don’t need fludrocortisone because mineralocorticoid secretion is not under ACTH control. Aldosterone secretion from the contralateral adrenal gland isn’t impacted.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Definition of cushing’s syndrome

A

presentation of cortisol excess (due to a variety of causes)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

definition of cushing’s disease

A

cortisol excess due to pituitary adenoma secreting ACTH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Use of phenoxybenzamine

A

Preoperative alpha-receptor blockade for 10-14 days before surgery for pheochromocytomas and paragangliomas to prevent hypertensive crises during surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

How to test for hypogonadism

A
  • Measure 8AM testosterone

- IF low repeat, second 8AM testosternoe

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Hypogonadism diagnosis

A

2 low AM testosterone levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Monitoring of chronic hypoparathyroidism

A
  • monitor urine calcium excretion (without PTH, urinary calcium excretion is higher than normal for any given serum calcium level, which can lead to complications like kidney stones and impaired GFR) -
  • if calcium levels are high, calcium and/or vitamin d replacement needs to be decreased
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Management of hypothyroidism in pregnancy

A
  • increase synthroid dose by 30% (pregnant women with hypothyroidism are unable to augment thyroidal production of T4 and T3)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

First step after gender incongruence diagnosed in managing transgender patient

A

Refer for discussion of reproductive options

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

steps in transgender medicine before surgery

A
  • engage in at least 1 year of satisfactory social role change + consistent and compliant hormone treatment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Preconception counseling for diabetic women

A
  • dilated eye exam (at increased risk of developing diabetic retinopathy because rapid increases in glycemic levels during pregnancy can worsen preexisting retinopathy)
44
Q

Management of steroid-induced osteoporosis

A
  • need osteoporosis screening within 6 months of initiation of long-term steroids
  • Oral bisphosphonates (alendronate) for anyone with Z score less than -3 and steroid treatment of >7.5 mg/day for 6 or more months
45
Q

Lab features of thyroid adenoma

A
  • Elevated free T4

- Inappropriately normal or elevated TSH level

46
Q

“Honey moon” phase of type 1 DM

A
  • Drastic reduction in endogenous insulin production creates glucose toxicity that impairs remaining beta cells –> as exogenous insulin improves glycemic control, remaining beta cells experience less tress and start secreting more endogenous insulin –> thus people have rapid glycemic control and low A1c’s and need very little endogenous insulin
47
Q

Management of honey moon phase of DM1

A

Decrease both prandial and long acting insulin

48
Q

Denosumab trade name

A

xgeva

49
Q

Management of denosumab

A

Continue indefinitely! and don’t get DEXAs, which won’t change management (it circulates in the blood for up to 9 months after subcutaneous injection, but once cleared, resorption transiently but dramatically increases, which can cause abrupt decline in bone mineral density and vertebral fractures

50
Q

Management of patient with type 1 DM who is NPO

A
  • decrease basal insulin (require basal insulin or will go into DKA)
  • DC mealtime
  • add SSI
51
Q

Workup of adrenal incidentaloma

A

Screen for adrenal hyperfunction in all incidental adrenalomas
- test for pheo (even in absence if HTN because may exist in the absence of HTN and typical signs. they are now commonly discovered)
- test for Cushing
IF HTN –> screen for primary hyperaldo

52
Q

How to test for pheos

A

24 hr urine total metanephrine measurement

53
Q

Preferred screening for Cushing

A

1-mg overnight dexa suppression test

54
Q

Testing required before parathyroidectomy for primary hyperparathyroidism

A

25-hydroxyvitamin d (avoid postoperative hypocalcemia)

55
Q

What is subclinical cushing syndrome

A
  • ACTH resulting in metabolic (hyperglycemia and HTN) and bone abnormalities but no Cushing syndrome (obesity, facial plethora, fat deposition, striae)
56
Q

Primary hyperaldo aldosterone-renin ratio cutoff for diagnosis

A

Aldosterone-renin ratio of less than 20

57
Q

How to screen for Cushing syndrome in a pt who works night shifts

A

24-hour urine free cortisol

58
Q

Usual cause of hypothyroid patients requiring increasingly higher doses of synthroid

A

Malabsorption syndromes

59
Q

Term for rash with celiacs

A

dermatitis herpetiformis

60
Q

Celiac features

A
  • abdominal pain
  • weight loss
  • rash
61
Q

management of abnormal semen analysis

A

Repeat in 2 weeks, if abnormal, refer to reproductive endocrinologist

62
Q

Endocrine effects of chronic opioid use

A

hypogonadism

63
Q

Turner syndrome clinical features

A
  • short

- neck webbing, hearing loss, aortic coarctation, bicuspid aortic valve

64
Q

Evaluation of postprandial hypoglycemia

A
  • mixed-meal test (consisting of types of food that normally induce hypoglycemia
65
Q

Management of secondary adrenal insufficiency (eg after discontinuation of steroids)

A

hydrocortisone (no mineralocorticoid deficiency in secondary AI)

66
Q

Treatment of primary adrenal insufficiency

A

hydrocortisone and fludrocortisone

67
Q

Levothyroxine dosing

A
  • weight-based
  • except in older adults (over age 65) and patients with cardiovascular disease (due to effects of thyroid hormone on myocardial oxygen demand)
68
Q

First step after diagnosis of Cushing syndrome (hypercortisolism diagnosed)

A

ACTH level (to determine if ACTH dependent or independent)

69
Q

Management of postmenopausal osteoporosis

A

Bisphosphonates

70
Q

medications to hold before screening for secondary HTN

A

Spironolactone

71
Q

A1c goal for older adults with complex medical history

A

7.5-8.0%

72
Q

Endocrine SE’s of checkpoint inhibitors

A

Hypophysitis (headache, pituitary enlargement, and hypopituitarism)

73
Q

Indication for adrenalectomy with adrenal masses

A
  • radiologic featrues suggestive of increased risk of malignancy:
    size >4 cm
    density >10 hounsfield units
  • contrast washout <50% at 10 minutes
74
Q

Work up of hypocalcemia

A

1) exclude hypomagnesemia (hypomagnesemia causes functional reversible PTH hypofunction)
2) check PTH

75
Q

Cutoff for using metformin in CKD

A

EGFR>45

76
Q

most common causes of hyperthyroidism

A

Toxic adenoma

Multinodular goiter

77
Q

Treatment of toxic adenoma

A
  • Radioactive iodine or surgery
78
Q

to do for initial diagnosis of DM2 visit

A
  • dilated eye exam
  • spot urine albumin-creatinine ratio
  • foot exam
79
Q

Management of diabetic patient with preprandial blood glucose levels at goal but A1c not at goal

A

Measure postprandial blood glucose level (may detect undetected hyperglycemia that could be treated with an increase in prandial insulin)

80
Q

Preprandial/fasting glycemic goals

A

80-130

81
Q

Management of primary hyperparathyroidism

A

IF asymptomatic –> monitor serum calcium and creatinine q6-12 months + DEXAs q2 years
IF calcium greater than 1 mg above upper limit OR EGFR less than 60 OR 24-hour urine calcium greater than 400 mg/day OR incrreased stone risk/renal stones OR T-score less than or equal to negative 2.5 –> parathyroidectomy

82
Q

Indications for parathyroidectomy

A
  • calcium greater than 1 mg above upper limit
  • EGFR less than 60 OR 24-hour urine calcium greater than 400 mg/day
  • increased stone risk or presence of renal stones
  • T-score less than or equal to negative 2.5
83
Q

Testing prior to parathyroidectomy

A

Parathyroid sestamibi scan

84
Q

Management of hypercalcemia in patients with primary hyperparathyroidism

A

IF meeting indications –> parathyroidectomy

- Cinacalcet only used in adults in whom parathyroidectomy can’t be performed

85
Q

Workup of patient with primary hyperPTH prior to endocrine referral

A

DEXA

86
Q

Initial step following diagnosis of subclinical hypothyroidism

A
  • Repeat TSH/T4 (rule out transient elevation of serum TSH)
87
Q

Lab findings in Hashimoto thyroiditis

A

Positive thyroid peroxidase antibodies

88
Q

When to measure T3

A

Never

89
Q

Next 2 steps after diagnosis of primary hyperaldo

A

Abdominal CT –> Once adenoma confirmed, Adrenal vein sampling (confirm source of hyperaldosteronism – in some cases adenomas aren’t visualized so you need to confirm source of secretion and lateralization. Also need to confirm hyperfunctioning)

90
Q

First step in evaluation of a thyroid nodule

A

Neck US (need to determine that biopsy is indicated + ensure no additional nonpalpable nodules that warrant fine needle biopsy)

91
Q

Secondary vs. primary hypothyroidism

A
Primary = inadequate function of the gland itself
Secondary = inadequate stimulation by TSH from pituitary gland
92
Q

Monitoring of secondary hypothyroidism post adrenal gland surgery

A
  • just check T4 not TSH (patient doesn’t have pituitary gland). Dose is titrated based on free T4.
93
Q

How to tell patients to take synthroid

A
  • On empty stomach, 1-3 hours after ingestion of food

- take separately from calcium or iron-containing supplements (4 hours apart)

94
Q

Management of hypoglycemic unawareness

A
  • reduce all insulin doses (need to provide body with an opportunity to restore the ability to detect hypoglycemia) (even if patient has elevated a1c)
95
Q

Age cutoff for osteoporosis screening

A

65 or older

96
Q

First 2 steps in myxedema coma management

A

FIRST STEP: Empiric treat for AI with Intravenous hydrocortisone (can discontinue if cortisol normal. if AI is present, giving thyroid hormone prior to steroids can precipitate adrenal crisis by augmenting cortisol metabolism)
Second step: IV synthroid

97
Q

Management of papillary thyroid carcinoma

A

Thyroid lobectomy. If completely resected, no adjuvant therapy.

98
Q

Management of metastatic papillary thyroid carcinoma

A

Lobectomy with adjuvant radioactive iodine therapy

99
Q

Diagnoses of diabetes insipidus

A

Urine and serum osmolality (low urine osmolality + high serum osmolality + hypernatremia in a patient with polyuria is diagnostic of DI)
- don’t need to do water deprivation test or desmopressin challenge

100
Q

Management of thyroid storm

A
  • beta blockers
  • antithyroid drug therapy
  • IV steroids
  • potassium iodide
101
Q

Management of amiodarone-induced thyrotoxicosis

A

If type 1 (vascularity on US) –> stop amio
If type 2 (no increased vascularity + no nodules or goiter) –> give steroids, continue amio, then decide on whether to continue amio (long half life so no immediate benefit to stopping + need to weigh risks/benefits of cardiac disease)

102
Q

Workup of rapid-onset hirsutism

A
  • Pelvic ultrasound (looking for androgen-secreting ovarian tumors)
    IF negative –> adrenal CT ( exclude adrenal cortisol-secreting neoplasm)
103
Q

Lab profile of osteomalacia

A
  • low 25-hydroxyvitamin D
  • low calcium
  • low phos
  • high PTH
104
Q

Osteogenesis imperfecta clinical features

A

Genetic syndrome leading to collagen abnormalities and…

  • short stature
  • body deformity
  • hearing loss
  • dental deformities
  • blue sclera
105
Q

Osteitis fibrosa cystica pathophys + classic patient

A
  • high bone turnover after prolonged exposure of bone to high levels of PTH in hyperparathyroidsm
  • CKD patients